• Users Online: 213
  • Print this page
  • Email this page
Year : 2018  |  Volume : 15  |  Issue : 4  |  Page : 295-299

Anti-müllerian hormone level in patients with polycystic ovary syndrome

1 Central Laboratory, General Duhok Directorate of Health, Iraqi Kurdistan, Duhok, Iraq
2 Department of Medical Laboratory Technology, Shekhan Technical College of Health, Duhok Polytechnic University, Duhok, Iraq

Correspondence Address:
Salar Mohammed Saadullah
Azadi Teaching Hospital, Duhok
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/MJBL.MJBL_98_18

Get Permissions

Background: Polycystic ovary syndrome(PCOS) is one of the common causes of chronic anovulation and hyperandrogenism in women between the age of 13 and 45years old. PCOS is characterized by an increased number of follicles at all growing stages particularly in the preantral and small antral follicles, those who primarily produce Anti-Müllerian hormone(AMH). Objective: The aim of the study is to measure the AMH levels in serum of the women with PCOS. Materials and Methods: The study included 90 women(50cases with PCOS and 40 control cases healthy women). PCOS patients were diagnosed according to the Rotterdam definition; serum AMH was measured using the ultrasensitive AMH enzyme-linked immunosorbent assay. Results: Mean serum of AMH in PCOS patients was 11.52ng/ml and for the control group was 3.36ng/ml and was statistically significant with the P <0.0001. Conclusions: AMH is elevated in PCOS patients, which can be used in the future as a marker for the diagnosis of PCOS.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded150    
    Comments [Add]    

Recommend this journal